{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:24:59Z","timestamp":1777461899053,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Stevenson Fellowship for Health Innovation and Quality Improvement"},{"name":"Roche Diagnostics International Ltd."},{"name":"Roche Diagnostics NZ Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.pcd.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T18:57:19Z","timestamp":1544468239000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["HbA1c screening in the community: Lessons for safety and quality management of a point of care programme"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6002-4766","authenticated-orcid":false,"given":"Timothy","family":"Kenealy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Herd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarina","family":"Musaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2018.11.008_bib0005","unstructured":"Health targets: More heart and diabetes checks. www.health.govt.nz\/new-zealand-health-system\/health-targets\/about-health-targets\/health-targets-more-heart-and-diabetes-checks."},{"key":"10.1016\/j.pcd.2018.11.008_bib0010","unstructured":"Health targets \u2013 2013\/14 quarter four \u2013 results summary. http:\/\/www.health.govt.nz\/new-zealand-health-system\/health-targets\/how-my-dhb-performing\/how-my-dhb-performing-2013-14\/health-targets-2013-14-quarter-four-results-summary."},{"issue":"3","key":"10.1016\/j.pcd.2018.11.008_bib0015","first-page":"161","article-title":"Cultural and clinical effectiveness of the \u2018QAAMS\u2019 point-of-care testing model for diabetes management in Australian aboriginal medical services","volume":"27","author":"Shephard","year":"2006","journal-title":"Clin. Biochem. Rev."},{"issue":"4","key":"10.1016\/j.pcd.2018.11.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174504","article-title":"The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: a cluster randomised controlled trial and qualitative investigation","volume":"12","author":"Wells","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2018.11.008_bib0025","series-title":"Laboratory Quality Management System Handbook","author":"World Health Organization","year":"2011"},{"issue":"1362","key":"10.1016\/j.pcd.2018.11.008_bib0030","article-title":"Understanding the new HbA1c units for the diagnosis of type 2 diabetes","volume":"125","author":"Braatvedt","year":"2012","journal-title":"N. Z. Med. J."},{"issue":"6","key":"10.1016\/j.pcd.2018.11.008_bib0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"Sacks","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pcd.2018.11.008_bib0040","unstructured":"Roche Diagnostics Cobas b 101 Performance evaluation report. www.cobas.com\/content\/dam\/cobas_com\/pdf\/product\/cobas-b-101-system\/cobas%20b%20101%20performance%20evaluation%20study%20report_8pg.pdf."},{"issue":"6","key":"10.1016\/j.pcd.2018.11.008_bib0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/diacare.8.6.529","article-title":"Accuracy of perceiving blood glucose in IDDM","volume":"8","author":"Cox","year":"1985","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.pcd.2018.11.008_bib0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/dia.2013.0289","article-title":"Assessment of the performance of A1CNow(+) and development of an error grid analysis graph for comparative hemoglobin A1c measurements","volume":"16","author":"Jiang","year":"2014","journal-title":"Diabetes Technol. Ther."},{"issue":"8","key":"10.1016\/j.pcd.2018.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1373\/clinchem.2013.220772","article-title":"Utilization of assay performance characteristics to estimate hemoglobin A1c result reliability","volume":"60","author":"Woodworth","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pcd.2018.11.008_bib0060","series-title":"AACB 51st Annual Scientific Conference","article-title":"Evaluation of the Roche Cobas B 101 instrument","author":"Cowley","year":"2013"},{"issue":"1","key":"10.1016\/j.pcd.2018.11.008_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1373\/clinchem.2009.130641","article-title":"Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria","volume":"56","author":"Lenters-Westra","year":"2010","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.pcd.2018.11.008_bib0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1373\/clinchem.2014.224311","article-title":"Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria","volume":"60","author":"Lenters-Westra","year":"2014","journal-title":"Clin. Chem."},{"issue":"1383","key":"10.1016\/j.pcd.2018.11.008_bib0075","first-page":"72","article-title":"Point-of-care testing governance in New Zealand: a national framework","volume":"126","author":"Musaad","year":"2013","journal-title":"N. Z. Med. J."},{"issue":"1417","key":"10.1016\/j.pcd.2018.11.008_bib0080","first-page":"41","article-title":"Clinical goverance and point of care testing at health provider level","volume":"128","author":"Herd","year":"2015","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.pcd.2018.11.008_bib0085","series-title":"New Zealand Best Practice Guidelines For Point-of-Care Testing","author":"New Zealand Point-of-Care Testing Advisory Group","year":"2014"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181830144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181830144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:56:49Z","timestamp":1761695809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175199181830144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S175199181830144X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2018.11.008","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HbA1c screening in the community: Lessons for safety and quality management of a point of care programme","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}